Diseases, Conditions, Syndromes

Major COVID-19 vaccine trial resumes in UK after safety review

Pharma giant AstraZeneca and Oxford University on Saturday said they had resumed a COVID-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.

Diseases, Conditions, Syndromes

Second AstraZeneca almost doubles protection against Delta variant

The weekend's news of COVID-19 outbreaks and various lockdowns around Australia reminds us there's no room for complacency. We need to accelerate Australia's COVID-19 vaccine roll-out and ensure people are fully vaccinated ...

Vaccination

British woman dies in Cyprus after AstraZeneca jab

A 39-year-old British woman died in a Cypriot hospital after a blood clotting incident after receiving the AstraZeneca COVID-19 vaccine, the official Cyprus News Agency said Monday.

Vaccination

EMA official suggests ditching AstraZeneca jab

A top official in the European Medicines Agency said it might be worth abandoning AstraZeneca's coronavirus vaccine for all age groups where alternatives are available, in an interview published Sunday.

Oncology & Cancer

Faulty gene connected to ovarian cancer risk

In a new study published in Nature Genetics researchers say that women who possess a fault in a gene named RAD51D have a greater risk of developing ovarian cancer than women who do not have this fault and tests are expected ...

page 2 from 34